A. Koito

发表

Human Immunodeficiency Virus Type 1 Vpr Modifies Cell Proliferation via Multiple Pathways

H. Nakauchi, T. Yamaguchi, N. Watanabe, 1999, Microbiology and immunology.

Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR*

N. Najimudin, A. Koito, A. Saito, 2011, The Journal of Biological Chemistry.

Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization

C. Cheng‐Mayer, J. Levy, A. Koito, 1994, Journal of virology.

Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients.

H. Masutani, A. Koito, K. Takatsuki, 1992, AIDS research and human retroviruses.

Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.

S. Matsushita, A. Koito, K. Yoshimura, 2007, The Journal of infectious diseases.

Differential Level in Co‐Down‐Modulation of CD4 and CXCR4 Primed by HIV‐1 gp120 in Response to Phorbol Ester, PMA, among HIV‐1 Isolates

H. Nakauchi, T. Yamaguchi, A. Koito, 2000, Microbiology and immunology.

Fumagillin suppresses HIV‐1 infection of macrophages through the inhibition of Vpr activity

H. Miyoshi, A. Koito, Tomoyuki Yamaguchi, 2006, FEBS letters.

Glycoglycerolipid from the Membranes of Acholeplasma laidlawii Binds to Human Immunodeficiency Virus-1 (HIV-1) and Accelerates Its Entry into Cells

Takashi Shimizu, A. Koito, M. Hirama, 2004, Current Microbiology.

Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy.

S. Matsushita, Feng-xiang Wang, A. Koito, 2002, The Journal of infectious diseases.

A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-alpha-trypsin inhibitor.

S. Matsushita, A. Koito, K. Takatsuki, 1989, International immunology.

Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.

S. Matsushita, A. Koito, K. Takatsuki, 1989, Antiviral research.

Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication.

S. Matsushita, A. Koito, H. Shigekane, 2003, Virology.

Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infection

N. Katunuma, H. Kido, A. Koito, 1989, FEBS letters.

Inhibition of Human Immunodeficiency Virus Infection of Human Lymphocytes by Gangliosides

A. Koito, K. Takatsuki, T. Kawaguchi, 1989, Japanese journal of cancer research : Gann.

Creation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities

A. Koito, N. Watanabe, E. Ong, 2016, Scientific Reports.

GANP Interacts with APOBEC3G and Facilitates Its Encapsidation into the Virions To Reduce HIV-1 Infectivity

A. Koito, Mayuko Shimoda, M. Goodman, 2013, The Journal of Immunology.

to Reduce HIV-1 Infectivity Facilitates Its Encapsidation into the Virions GANP Interacts with APOBEC3G and

A. Koito, Mayuko Shimoda, P. Pham, 2013 .

Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases

Terumasa Ikeda, A. Koito, Atsushi Koito, 2013, Front. Microbio..

Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons

T. Heidmann, A. Koito, T. Sata, 2011, Nucleic acids research.

Current Topics in Prevention of Human T-Cell Leukemia Virus Type I Infection: NF-κ B Inhibitors and APOBEC3

A. Koito, T. Ohsugi, 2008, International reviews of immunology.

Infection : NF-κ B Inhibitors and APOBEC 3

A. Koito, T. Ohsugi, 2008 .

Susceptibility of Mink (Mustera vision)-Derived Cells to Replication by Human Immunodeficiency Virus Type 1

C. Cheng‐Mayer, S. Matsushita, A. Koito, 2003, Journal of Virology.

Apolipoprotein B mRNA‐editing, catalytic polypeptide cytidine deaminases and retroviral restriction

A. Koito, Terumasa Ikeda, 2012, Wiley interdisciplinary reviews. RNA.

Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B).

S. Matsushita, A. Koito, K. Takatsuki, 1987, Japanese journal of cancer research : Gann.

Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3.

A. Koito, T. Ohsugi, 2007, Journal of virological methods.

The antiretroviral potency of APOBEC1 deaminase from small animal species

S. Matsushita, A. Koito, Tetsuya Kimura, 2008, Nucleic acids research.

Disturbed CD4+ T Cell Homeostasis and In Vitro HIV-1 Susceptibility in Transgenic Mice Expressing T Cell Line–tropic HIV-1 Receptors

G. Suzuki, Misao Suzuki, A. Koito, 1998, The Journal of experimental medicine.

Paroxysmal nocturnal haemoglobinuria with coexisting deficiency of the ninth component of complement: lack of massive haemolytic attack

A. Koito, M. Kawakita, K. Takatsuki, 1990, British journal of haematology.

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

S. Matsushita, M. Robert-Guroff, A. Koito, 1988, Journal of virology.

Selective killing of HIV-infected cells by anti-gp120 immunotoxins.

S. Matsushita, A. Koito, K. Takatsuki, 1990, AIDS research and human retroviruses.

Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors.

S. Matsushita, M. Matsuoka, A. Koito, 1987, Japanese journal of cancer research : Gann.

Coreceptor Function of Mutant Human CD4 Molecules without Affinity to gp120 of Human Immunodeficiency Virus*

M. Siddiqi, A. Koito, K. Eshima, 2000, The Journal of Biological Chemistry.

APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo

M. Matsuoka, S. Wain-Hobson, J. Vartanian, 2010, Journal of Virology.

Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity

A. Koito, Mayuko Shimoda, J. VandeBerg, 2017, Scientific Reports.

Intrinsic restriction activity by AID/APOBEC family of enzymes against the mobility of retroelements

A. Koito, Terumasa Ikeda, 2011, Mobile genetic elements.

Frequent infection with human T-cell lymphotropic virus type I in patients with AIDS but not in carriers of human immunodeficiency virus type 1.

K. Matsumoto, A. Koito, K. Takatsuki, 1989, Journal of acquired immune deficiency syndromes.

Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120.

L. Stamatatos, C. Cheng‐Mayer, A. Koito, 1995, Virology.

Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy.

S. Matsushita, A. Koito, K. Nishihara, 2002, The Journal of infectious diseases.

Impact of V2 Mutations on Escape from a Potent Neutralizing Anti-V3 Monoclonal Antibody during In Vitro Selection of a Primary Human Immunodeficiency Virus Type 1 Isolate

S. Matsushita, A. Koito, K. Yoshimura, 2007, Journal of Virology.

Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses.

S. Matsushita, A. Koito, K. Takatsuki, 1988, AIDS research and human retroviruses.

Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors

S. Matsushita, H. Mitsuya, A. Koito, 2006, AIDS.

Phosphorothioate hammerhead ribozymes targeting a conserved sequence in the V3 loop region inhibit HIV-1 entry.

A. Koito, Y. Iwatani, T. Hattori, 1998, Antisense & nucleic acid drug development.

Retroviruses, retroelements and their restrictions

A. Koito, Y. Ishizaka, 2013, Frontiers in Microbiology.

Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247.

S. Matsushita, A. Koito, Tetsuya Kimura, 2006, Human antibodies.

Erratum: Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy (Journal of Infectious Disease (2002) 185 (608-617))

S. Matsushita, A. Koito, K. Nishihara, 2002 .

APOBEC3G Generates Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo (cid:1)

J. Vartanian, A. Koito, K. Nosaka, 2010 .